Clinical Trial Update: Low-Dose Atropine for Treatment of Myopia [Phase 3]

View source ↗

Summary

Phase 3 trial update on low-dose atropine for treatment of myopia has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Low-dose atropine (atropine)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Myopia | Phase 3 | Status: COMPLETED | Results posted: 2023-05-11